Abattis Bioceuticals Corp. (ATTBF.PK) Wednesday said it has been granted Intl Class 5 Trademark for DefenZall in Taiwan and the U.S.
Mike Withrow, CEO, said, “We are pleased to extend the intellectual property of the company as we grow our brands. This mark will be used to brand our proprietary Anti-Viral Nutraceutical Platform of products…”
These products are DefenZall Daily, DefenZall Immune Support and DefenZall Serious Defense. They will be launched through the company’s Canadian distributor Hedley Enterprises, on the Internet and through the distributor in Hong Kong.
by RTT Staff Writer
For comments and feedback: editorial@rttnews.comBusiness News